OMX Copenhagen 20

OMX Copenhagen 20 handeln
1.544,40 PKT +5,93 PKT +0,39 %
finanzen.net zero
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Smartphone

WKN A0AEM7


Analysen zu OMX Copenhagen 20-Werten

Datum Rating Analyst
20.10.17 Novo Nordisk Equal-Weight Morgan Stanley
19.10.17 Novo Nordisk Neutral Citigroup Corp.
19.10.17 Novo Nordisk Underweight JP Morgan Chase & Co.
17.10.17 Novo Nordisk buy Goldman Sachs Group Inc.
17.10.17 Novo Nordisk buy UBS AG
17.10.17 Novo Nordisk Equal-Weight Morgan Stanley
17.10.17 Novo Nordisk Reduce HSBC
16.10.17 Novo Nordisk Hold Jefferies & Company Inc.
13.10.17 Novo Nordisk Underweight JP Morgan Chase & Co.
10.10.17 Novo Nordisk Reduce HSBC
09.10.17 Novo Nordisk buy Goldman Sachs Group Inc.
25.09.17 Novo Nordisk Neutral BNP PARIBAS
18.09.17 Novo Nordisk Hold Jefferies & Company Inc.
13.09.17 Novo Nordisk Underweight JP Morgan Chase & Co.
07.09.17 Novo Nordisk Underweight JP Morgan Chase & Co.
06.09.17 Novo Nordisk Neutral Merrill Lynch & Co., Inc.
24.08.17 Novo Nordisk Hold Jefferies & Company Inc.
18.08.17 Novo Nordisk Hold Joh. Berenberg, Gossler & Co. KG (Berenberg Bank)
18.08.17 Novo Nordisk buy Goldman Sachs Group Inc.
17.08.17 Novo Nordisk buy UBS AG
17.08.17 Novo Nordisk Reduce HSBC
17.08.17 Novo Nordisk buy Goldman Sachs Group Inc.
15.08.17 Novo Nordisk Neutral Citigroup Corp.
11.08.17 Novo Nordisk Neutral Citigroup Corp.
10.08.17 Novo Nordisk buy Deutsche Bank AG
10.08.17 Novo Nordisk buy UBS AG
10.08.17 Novo Nordisk Underweight JP Morgan Chase & Co.
10.08.17 Novo Nordisk Underweight Barclays Capital
10.08.17 Novo Nordisk buy Goldman Sachs Group Inc.
10.08.17 Novo Nordisk Reduce HSBC
09.08.17 Novo Nordisk Hold S&P Capital IQ
04.08.17 Novo Nordisk Underweight JP Morgan Chase & Co.
01.08.17 Novo Nordisk buy Deutsche Bank AG
01.08.17 Novo Nordisk buy UBS AG
26.07.17 Novo Nordisk buy UBS AG
21.07.17 Novo Nordisk Underweight JP Morgan Chase & Co.
07.07.17 Novo Nordisk buy Deutsche Bank AG
30.06.17 Novo Nordisk Underweight JP Morgan Chase & Co.
27.06.17 Novo Nordisk Underweight JP Morgan Chase & Co.
26.06.17 Novo Nordisk Neutral Citigroup Corp.